Submitted by nedragarrett_CDC on 2022-09-27
|Submitted By: Keith W. Boone / Audacious Inquiry|
|Data Element Information|
|Use Case Description(s)|
|Use Case Description||Facility level data is associated with laboratory tests (the testing facility), and health care provider locations, including hospitals, ambulatory providers, long-term and post acute care, and pharmacy providers.
Location data is used to support reporting of data for public health and emergency response (e.g., situation awareness reporting).
See https://build.fhir.org/ig/HL7/fhir-saner/ for details (note that (minus) - is a legal character in URLs, had to use a bit.ly link to get past validation errors in URL)
|Estimated number of stakeholders capturing, accessing using or exchanging||Hospitals in the US (Approximately 7000), Laboratories (260,000), pharmacies (88,000), ambulatory physicians (260,000).|
|Link to use case project page||https://bit.ly/SANERBUILD|
|Maturity of Use and Technical Specifications for Data Element|
FHIR DSTU2, 3 and 4, CDA Release 2.0, HL7 V2 PL Data Type
|Additional Specifications||V3.1.0: https://www.hl7.org/fhir/us/core/StructureDefinition-us-core-location.html
|Current Use||Extensively used in production environments|
Widely available within EHR Systems, but not necessarily searchable.
https://fhir.cerner.com/millennium/r4/encounters/encounter/ (Reference to a Location resource)
https://api.evident.com/dstu2/encounter (Location as an embedded resource)
https://www.questdiagnostics.com/dms/Documents/care360/Terms-Conditions/Quanum_EHR_FHIR_API.pdf (Quest only supports Location name in Immunizations)
|Number of organizations/individuals with which this data element has been electronically exchanged||5 or more. This data element has been tested at scale between multiple different production environments to support the majority of anticipated stakeholders.|
See US Core Connectathon report out: https://drive.google.com/file/d/1WNYWLEf28j8DPyDachC8jpk-QbkyuPxP/view
|Restrictions on Standardization (e.g. proprietary code)||None|
|Restrictions on Use (e.g. licensing, user fees)||None|
|Privacy and Security Concerns||Locations associated with Critical Access Hospitals, and single provider facilities may constitute PHI (in geographic locations with limited populations) and/or Individual Identifiable Information (e.g., for HCPs working from a combined home/office facility).|
|Estimate of Overall Burden||Most electronic systems provide the capacity to store location and organization information. Many EHRs already provide access to the Location resource via READ operations, some (e.g., Epic, AthentaHealth) provide search capabilities as well. This information is routinely communicated in HL7 V2 Messages, CDA Documents and some FHIR API transactions. To address gaps, implementers would need to modify interfaces (e.g., for CDA or HL7 V2), or add an endpoint. Estimated effort (based on past experience building EHR systems) is about one two-week sprint to implement the capability by a developer.|
|Other Implementation Challenges||Standards for location identifier may need flexibility depending on use of Location for reportiong, as there are a number of distinct location identifier systems which may be necessary for different reporting use cases. For example, CDC/NHSN assigns identifiers for HAI reporting, CLIA assigns identifiers to laboratories, CMS provides location identifiers, et cetera.|
Submitted by nedragarrett_CDC on 2022-09-29
CDC's comment on behalf of CSTE for USCDI v4CSTE agrees with CDC's recommendation for this data element.